Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Co-receptor switch during HAART is independent of virological success.

Journal of medical virology - 1 Dec 2009

Saracino Annalisa, Monno Laura, Cibelli Donatella C, Punzi Grazia, Brindicci Gaetano, Ladisa Nicoletta, Tartaglia Alessandra, Lagioia Antonella, Angarano Gioacchino

Abstract excerpt

The influence of antiretroviral therapy on co-receptor tropism remains controversial. To verify if co-receptor tropism shift was affected by HAART, the evolution of proviral DNA V3 genotype after 12 months of a new antiretroviral regimen was compared between responder and non-responder patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count
Share to HIV Envelope Protein gp120

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Peptide Fragments

Share to Receptors, CCR5

Share to Receptors, CXCR4

Share to Viral Tropism

Source

Identifiers

PMID: 19856465
DOI: 10.1002/jmv.21598

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19856465-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Co-receptor switch during HAART is independent of virological success.PMID 19856465Read ↗

Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients.Semantic proximity Read ↗

Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching.Semantic proximity Read ↗

Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.Semantic proximity Read ↗

HIV co-receptor tropism prediction remains stable over time in treatment-naïve patients.Semantic proximity Read ↗

HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.Semantic proximity Read ↗

R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.Semantic proximity Read ↗

Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy.Semantic proximity Read ↗

APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1.Semantic proximity Read ↗

High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.Semantic proximity Read ↗

Pitfalls of HIV genotypic tropism testing after treatment interruption.Semantic proximity Read ↗

Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populationsSemantic proximity Read ↗

Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.